Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Glenn J. Bubley, M.D.

Co-Author

This page shows the publications co-authored by Glenn Bubley and Irving Kaplan.
Connection Strength

0.886
  1. Accuracy of endorectal magnetic resonance/transrectal ultrasound fusion for detection of prostate cancer during brachytherapy. Urology. 2013 Jun; 81(6):1284-9.
    View in: PubMed
    Score: 0.532
  2. Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1416-1422.
    View in: PubMed
    Score: 0.231
  3. The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillance. Urol Oncol. 2021 11; 39(11):783.e21-783.e30.
    View in: PubMed
    Score: 0.059
  4. Prostate cancer in a transgender woman 41 years after initiation of feminization. JAMA. 2006 Nov 15; 296(19):2316-7.
    View in: PubMed
    Score: 0.021
  5. Analysis of hormonal receptor status in tissue from prostate cancer that developed 26 years after bilateral orchiectomy and following 41 years of estrogen therapy. J Clin Oncol. 2006 Jun 20; 24(18_suppl):14610.
    View in: PubMed
    Score: 0.021
  6. Her-2-neu expression and progression toward androgen independence in human prostate cancer. J Natl Cancer Inst. 2000 Dec 06; 92(23):1918-25.
    View in: PubMed
    Score: 0.014
  7. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol. 1994 Dec; 12(12):2634-9.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.